Latest News: Veeda Clinical raises $16 mn from Sabre Partners Veeda Clinical Research acquires a majority stake in Bioneeds

Webinars

The growing prominence of Tyrosine Kinase Inhibitors (TKIs) and its Bioequivalence Studies

Stereo-isomeric drugs and Bioanalysis

Long-Acting Injectable Antipsychotics

Regulatory & Pharmacovigilance Considerations for NCEs

India's Resurgence as a Clinical Trial Destination

Approaches used in Replicate Bioequivalence Studies

First in Man Studies – Strategies for a Successful Outcome.

Population Bioequivalence for In-Vitro Studies.

Request for Proposal

Submit your details and we’ll be in touch shortly. You can also email us if you would prefer.